首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Neuro-oncology

缩写:NEURO-ONCOLOGY

ISSN:1522-8517

e-ISSN:1523-5866

IF/分区:13.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3796
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Tong Tong,Josephine D Hendriksen,Kirstine J Elbæk et al. Tong Tong et al.
Background: Electrophysiological features of glioblastoma cells (GBCs) remain largely elusive, challenging our comprehension of glioblastoma pathophysiology. Spiking GABAergic-OPC tumor cells were recently described in ID...
Nitish Jangde,Mi Hye Lee,Luz Ruiz et al. Nitish Jangde et al.
Background: Medulloblastoma (MB) is the most common malignant brain tumor of childhood, and current treatments cannot sufficiently inhibit tumoral growth, leptomeningeal dissemination, and metastasis. RAC1, a low molecula...
Jiayi Lin,Lun Liang,Xupeng Zhu et al. Jiayi Lin et al.
Background: Brain metastases are a leading cause of mortality in non-small cell lung cancer (NSCLC) patients. Chemoresistance-induced metastasis remains a significant challenge in NSCLC. This study investigates whether ci...
Minjie Fu,Yuan Feng,Pin Sun et al. Minjie Fu et al.
Background: H3-altered gliomas, now recognized by WHO CNS5 as grade 4 neoplasms driven by histone H3 mutations (notably H3K27M and H3G34R/V), exhibit marked molecular heterogeneity, dismal survival, and resistance to stan...
Theophilos Tzaridis,Jingbo Liu,Franklin Lee Chien et al. Theophilos Tzaridis et al.
Background: Medulloblastoma is the most common malignant pediatric brain tumor, and has an urgent need for novel treatment approaches. Dordaviprone (ONC201) and its chemical derivative with nanomolar potency, ONC206, indu...
Stuart A Grossman,Amy Barone,Roy E Strowd et al. Stuart A Grossman et al.
Current assessments of brain permeability rely predominantly on drug delivery to contrast-enhancing tumor regions. However, substantial portions of central nervous system (CNS) tumors reside within non-enhancing brain (NEB), where drug conc...